Dopamine - Molecule of the Month October 2008 - HTML-only version

Drp1 inhibition attenuates neurotoxicity and dopamine release deficits in vivo

Frontiers Downregulation of cyclic adenosine monophosphate levels in leukocytes of hibernating captive black bears is similar to reported cyclic adenosine monophosphate findings in major depressive disorder

Evaluation of Urea-Based Inhibitors of the Dopamine Transporter Using the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis

The Dopamine Molecule

Preservation of dendritic D2 receptor transmission in substantia nigra dopamine neurons with age

Biology, Free Full-Text

Surface Modification of Halloysite Nanotubes with Dopamine for Enzyme Immobilization

Deciphering the Interregional and Interhemisphere Proteome of the Human Brain in the Context of the Human Proteome Project

Direct in Vivo Electrochemical Detection of Resting Dopamine Using Poly(3,4-ethylenedioxythiophene)/Carbon Nanotube Functionalized Microelectrodes

Dysbindin-1A modulation of astrocytic dopamine and basal ganglia dependent behaviors relevant to schizophrenia

Neuronal implementation of the temporal difference learning algorithm in the midbrain dopaminergic system

An expanded palette of dopamine sensors for multiplex imaging in vivo

Dopamine - Molecule of the Month October 2008 - HTML-only version

SIRT3 Activation a Promise in Drug Development? New Insights into SIRT3 Biology and Its Implications on the Drug Discovery Process